Mangafodipir
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Mangafodipir, covering 2010-05-04 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients. [Phase 2]